Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change.

Zhou Z, Ibekwe E, Chornenkyy Y.

Antioxidants (Basel). 2018 Jan 17;7(1). pii: E16. doi: 10.3390/antiox7010016. Review.

2.

Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma.

Zhou Z, Howard TA, Villano JL.

Cancer Chemother Pharmacol. 2017 Nov;80(5):1043-1046. doi: 10.1007/s00280-017-3415-5. Epub 2017 Aug 8.

PMID:
28791452
3.

Chronic Neuropsychological Sequelae in a Patient with Nontumorous Anti-NMDA-Receptor Encephalitis.

Han DY, Koehl LM, Patel A, Zhou Z, Phillips S, Kapoor S.

Case Rep Neurol Med. 2017;2017:5675732. doi: 10.1155/2017/5675732. Epub 2017 Apr 19.

4.

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes.

Zhou Z, Bachstetter AD, Späni CB, Roy SM, Watterson DM, Van Eldik LJ.

J Neuroinflammation. 2017 Apr 5;14(1):75. doi: 10.1186/s12974-017-0845-2.

5.

MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses.

Bachstetter AD, Zhou Z, Rowe RK, Xing B, Goulding DS, Conley AN, Sompol P, Meier S, Abisambra JF, Lifshitz J, Watterson DM, Van Eldik LJ.

PLoS One. 2016 Feb 12;11(2):e0149451. doi: 10.1371/journal.pone.0149451. eCollection 2016.

6.

Supplemental Content

Loading ...
Support Center